Because human mutations in leptin/leptin receptor are rare [43,44] and because leptin levels increase with NAFLD severity [45], these models may not accurately represent the pathogenesis of NAFLD. The gene discussed is LEPR; the disease is metabolic dysfunction-associated steatotic liver disease.